Annex A 
 
 
 
   
   
   
   
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
MA (EU) number 
(Invented) name 
Strength 
Pharmaceutical Form 
100 mg / 25 mg 
Film-coated tablet 
Route of 
Administration 
Oral use 
Immediate 
Packaging 
Blister 
Pack size 
60 tablets 
EU/1/15/1067/001 
EU/1/15/1067/002 
EU/1/15/1067/003 
EU/1/15/1067/004 
EU/1/15/1067/005 
EU/1/15/1067/006 
EU/1/15/1067/007 
EU/1/15/1067/008 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
Lopinavir/Ritonavir 
Mylan 
100 mg / 25 mg 
Film-coated tablet 
Oral use 
Unit-dose blister 
60x1 tablets 
100 mg / 25 mg 
Film-coated tablet 
Oral use 
Bottle (HDPE) 
60 tablets 
200 mg / 50 mg 
Film-coated tablet 
Oral use 
200 mg / 50 mg 
Film-coated tablet 
Oral use 
Blister 
Blister 
120 tablets 
360 tablets 
200 mg / 50 mg 
Film-coated tablet 
Oral use 
Blister (unit-dose) 
120x1 tablets 
200 mg / 50 mg 
Film-coated tablet 
Oral use 
Bottle (HDPE) 
360 tablets 
200 mg / 50 mg 
Film-coated tablet 
Oral use 
Bottle (HDPE) 
120 tablets 
 
 
 
 
